Related Experiment Video
Updated: Jul 31, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
14.6K
Inactivation of spinal cord stimulator implanted pulse generators after elective surgery: an under-recognized problem
Jordan N Norris1, Nathan Esplin2, Rosh Bharthi3
1University of Toledo College of Medicine and Life Sciences, 3000 Arlington Ave, Toledo, OH, 43614, USA. Jordan.Norris2@rockets.utoledo.edu.
Spinal Cord Series and Cases
|July 11, 2023
Summary
Spinal cord stimulation (SCS) implanted pulse generators (IPGs) can become inactivated during non-SCS surgeries, with 3% of devices affected. Many require replacement surgery, highlighting a need for preventative measures.
Area of Science:
- Neurosurgery
- Biomedical Engineering
- Pain Management
Background:
- Spinal cord stimulation (SCS) implanted pulse generators (IPGs) are susceptible to damage during subsequent surgeries.
- Current protocols for protecting IPGs during surgery vary, with some recommending deactivation which may lead to complications.
Purpose of the Study:
- To investigate the real-world prevalence and management of SCS IPG inactivation following non-SCS surgeries.
- To identify factors contributing to IPG inactivation and inform preventative strategies.
Main Methods:
- Retrospective analysis of a single-surgeon database of 490 SCS IPG implantations (2016-2022).
- Identification and analysis of cases where IPGs were inactivated after non-SCS procedures.
- Review of five illustrative patient cases detailing management and outcomes.
Main Results:
- 15 out of 490 (3%) SCS IPGs were inactivated after non-SCS surgery.
- 80% (12 patients) required surgical IPG replacement; 20% (3 patients) had function restored non-operatively.
- Surgery mode was frequently not activated prior to the non-SCS procedure.
Conclusions:
- Surgical inactivation of SCS IPGs is a significant issue, likely caused by electrocautery.
- Premature IPG replacement increases risks and reduces the cost-effectiveness of SCS therapy.
- Increased awareness and preventative measures are crucial for surgeons, patients, and manufacturers to mitigate IPG damage.

